FinTechFunding

Imagion Biosystems: Completes $6M placement

  • Imagion Biosystems (IBX) has completed a placement and raised $6 million
  • The placement was cornerstone by four Australian-based institutional investors and was led by Evolution Capital Advisors
  • More than 76.5 million shares will now be issued at 8.5 cents, representing a 6 percent discount to the 30-day volume-weighted average price
  • Imagion will use the funds to speed-up development plans and begin investing in manufacturing scale-up of its MagSense technology
  • Additionally, the company’s phase one study for HER2 metastatic breast cancer is scheduled to begin this quarter
  • Imagion is down 4 percent on the market, with shares currently trading for 12 cents each
Previous article
Zip Co: Unveils record numbers in first four months of FY21
Next article
Factory_OS: Raises $55M in Series B Funding
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

NatWest Group Strengthens Free Investment Guidance Programme

New initiative aims to educate more customers on investing.Highlights: NatWest Group expands free investment guidance programme.Initiative targets educating...
FinTech

Tether Launches New Stablecoin Wallet to Enhance User Experience

This innovative platform aims to improve accessibility for crypto users.Highlights: Tether has introduced a new stablecoin wallet.The wallet...
FinTech

FCA Strengthens Money Laundering Combat with Synthetic Dataset

New collaboration aims to enhance detection capabilities against financial crime.Highlights: FCA partners with Turing Institute to combat money...
FinTech

Spektr Strengthens Compliance Efforts with $20M Funding

Fintech startup Spektr secures $20 million for AI-driven compliance solutions.Highlights: Spektr raises $20 million to enhance its AI...